Alan Walts, Ph.D.


Dr. Walts has served as Executive Chairman since February 2017 and has been an advisor to Artax since July 2015. Alan also serves as Executive Chairman of PIC Therapeutics, Chairman of Aura Biosciences, is a co-founder and Board Observer of Arrakis Therapeutics, a Board Observer of Amylyx Pharmaceuticals, and is a Director of the Termeer Foundation. Dr. Walts is a US-based Venture Partner with Advent Life Sciences and is an Advisory Board member of the ALS Investment Fund.  Dr. Walts has over 25 years of industry experience at Genzyme in business development, business strategy, research and development, general management, and venture capital. Prior to leaving Genzyme in 2013, he most recently managed Genzyme’s corporate venture fund, Genzyme Ventures (now Sanofi Ventures).  Dr. Walts received a Ph.D. in chemistry from MIT in 1985, carried out post-doctoral research in biochemistry at MIT with Professor Christopher Walsh, and completed the executive Program for Management Development at Harvard Business School.